Boosting clearance of mitochondria may help treat Parkinson’s: Study

A recent study highlights the crucial role of the proteins NAP1 and SINTBAD in regulating mitophagy, a process essential for maintaining cellular health by removing damaged mitochondria. Mitophagy dysfunction is implicated in Parkinson’s disease, where impaired clearance of damaged mitochondria is believed to contribute to the loss of dopamine-producing nerve cells. The research, led by Michael Lazarou, PhD, from the Walter and Eliza Hall Institute (WEHI) in Australia, uncovered that NAP1 and SINTBAD initially inhibit the activation of PINK1/PRKN-mediated mitophagy by competing with other proteins for binding. However, when mitochondrial damage becomes severe, these proteins transition to a supportive role, promoting mitophagy by facilitating the recruitment of cellular machinery to degrade the damaged mitochondria. This discovery provides new insights into the complex regulation of mitophagy and suggests potential therapeutic strategies for diseases associated with mitochondrial dysfunction, such as Parkinson’s disease.